期刊文献+

晚期结直肠癌术前评估及治疗策略 被引量:8

Preoperative evaluation and treatment strategies for ad-vanced colorectai cancer
原文传递
导出
摘要 晚期结直肠癌主要分为局部晚期、术后局部复发及远处转移,远处转移主要包括腹膜转移及肝、肺等全身脏器的转移。手术切除是可能治愈晚期结直肠癌的惟一手段。术前以影像学评估为主,特别是对结直肠癌肝转移患者转移病灶可切除性的评估是外科治疗中尤其值得关注的问题。新辅助治疗及辅助治疗增加了晚期结直肠癌患者原发及转移病灶的手术切除率。近10年来,随着肿瘤外科的发展,多学科团队治疗模式的提出和实施,不仅使患者最大限度的受益,延长患者的生存时间,同时最大限度提高了患者的生命质量。 Advanced colorectal cancer mainly classi- fied as locally advanced, locally recurrent and distally metastatic colorectal cancer. Distal metastasis of colorectal cancer includes peritoneal metastasis, liver, lung and other organ metastasis. Surgical resection remains the only possible cure for patients with advanced colorectal cancer. Preoperative systemic evaluation based on radiographic images, especially the evaluation on the resectability of hepatic metastatic lesions from colorectal cancer is very important. Neo-adjuvant and adjuvant therapy increased the resection rate of primary and metastatic lesions of advanced colorectal cancer. In recent 10 years, with the development of oncological surgery, treatment modality of multi-disciplinary team has been proposed and implemented, which increased the survival time and improved the life quality of patients with color- ectal cancer.
作者 崔龙
出处 《中华消化外科杂志》 CAS CSCD 北大核心 2013年第6期409-412,共4页 Chinese Journal of Digestive Surgery
基金 上海交通大学医学院基金(11QYJ003)
关键词 结直肠肿瘤 术前评估 治疗策略 Colorectal neoplasms Preoperative eva-luation Treatment strategies
  • 相关文献

参考文献3

二级参考文献39

  • 1杜成雄,冯来运.大肠癌368例癌胚抗原及乙肝病毒检测结果分析[J].人民军医,2005,48(12):703-704. 被引量:3
  • 2Association of Breast Surgery @ BASO, Royal College orSurgeons of England. Guidelines for the management of symptomatic breast disease. Eur J Surg Oncol 2005; 31: S1-$21.
  • 3Stephens MR, Lewis WG, Brewster AE, Lord I, Blackshaw GR, Hodzovic I, et al. Multidisciplinary team management is associated with improved outcomesafter surgery for esophageal cancer. Dis Esophagus 2006; 19: 164-171.
  • 4Davies AR, Deans DA, Penman I, Plevris JN, Fletcher J, Wall L, et al. The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer. Dis Esophagus 2006; 19: 496-503.
  • 5' cancer/t Junor E J, Hole D J, Gillis CR. Management of ovarian Cancel referral to a multidisciplinary team matters. British J 1994; 70: 363-370.
  • 6McArdle CS, McKee RF, Finlay IG, Wotherspoon H, Hole DJ. Improvement insurvival following surgery for colorectal cancer. Br J Surg 2005; 92: 1008-1013.
  • 7Haward RA. Using service guidance to shape the delivery of cancer services: experience in the UK. Br J Cancer 2003; 89: S12-S14.
  • 8Figuerdo A, Coombes ME, Mukherjee S. Adjvuant therapy for completely resected stage II colon cancer. Cochrane Database of Systematic Reviews 2008; CD005390.
  • 9Benson AB 3rd, Schrag D, Somerfield MR, Cohen AMt Figueredo AT, Flynn P J, et al. American Society of Clinical Ontology recommendations on adjuvant chemotherapy fo stage lI colon cancer. J Clinl Oncol 2004; 15: 3408-3419. ].
  • 10Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial lNT-0089. J Clin Oncol 2003; 21: 2912-2919.

共引文献41

同被引文献88

  • 1李龙芸,周彩存,张国淳.非小细胞肺癌患者EGFR突变和基因扩增对吉非替尼疗效的预测价值[J].循证医学,2006,6(1):23-27. 被引量:2
  • 2张小辉,陈平.结肠癌气钡双重造影及CT检查的应用[J].罕少疾病杂志,2007,14(3):33-34. 被引量:3
  • 3Samani AA,Brodt P.The receptor for the type I insulin-like growth factor and ligands regrulate multiple cellular functions that impact on metastasis[J].Surg Oncol Clin N Am,2001,10(2):289-312
  • 4Favelyukis S,Till JH,Hubbard SR,et al.Structure and autoregulation of the insulin-like growth factor 1 receptor kinase[J].NatStruct Biol,2001,8(12):1058-1063
  • 5Grimberg A.Mechanisms by which IGF-I may promote cancer[J].Cancer Biol Ther,2003,2(6):630-635
  • 6King ER,Wong KK.Insulin-like growth factor:current concepts and new developments in cancer therapy[J].Recent Pat Anticancer Drug Discov,2012,7(1):14-30
  • 7Guix M,Faber AC,Wang SE,et al.Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGFbinding proteins[J].J Clin Invest,2008,118(7):2609-2619
  • 8Song RX,Chen Y,Zhang Z,et al.Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells[J].J Steroid Biochem Mol Biol,2010,118(4/5):219-230
  • 9Zhang Y,Moerkens M,Ramaiahgari S,et al.Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes[J].Breast Cancer Res,2011,13(3):R52
  • 10Stoehzing O,Liu W,Reinmuth N,et al.Regulation of hypoxia-inducible factor-1 alpha,vascular endothelial growth factor,and angiogenesis by all insulin-like growth factor-I receptor autoerine loop in human pancreatic cancer[J].Am J Pathol,2003,163(3):1001-1011

引证文献8

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部